CS227011B2 - Method of preparing substituted piperidines - Google Patents
Method of preparing substituted piperidines Download PDFInfo
- Publication number
- CS227011B2 CS227011B2 CS804889A CS488980A CS227011B2 CS 227011 B2 CS227011 B2 CS 227011B2 CS 804889 A CS804889 A CS 804889A CS 488980 A CS488980 A CS 488980A CS 227011 B2 CS227011 B2 CS 227011B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- methyl
- mepivacaine
- lidocaine
- formula
- hydroxyethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE7906000A SE431092B (sv) | 1979-07-10 | 1979-07-10 | Terapeutiskt aktiva, substituerade piperidinkarboxianilider |
Publications (1)
Publication Number | Publication Date |
---|---|
CS227011B2 true CS227011B2 (en) | 1984-04-16 |
Family
ID=20338488
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS804889A CS227011B2 (en) | 1979-07-10 | 1980-07-09 | Method of preparing substituted piperidines |
Country Status (19)
Country | Link |
---|---|
US (1) | US4302465A (da) |
EP (1) | EP0024382B1 (da) |
JP (1) | JPS5681561A (da) |
AT (1) | ATE6507T1 (da) |
AU (1) | AU538494B2 (da) |
CA (1) | CA1162924A (da) |
CS (1) | CS227011B2 (da) |
DE (1) | DE3066827D1 (da) |
DK (1) | DK290180A (da) |
ES (1) | ES8107185A1 (da) |
FI (1) | FI802173A (da) |
GR (1) | GR69077B (da) |
HU (1) | HU180156B (da) |
IL (1) | IL60390A (da) |
NO (1) | NO802062L (da) |
NZ (1) | NZ194284A (da) |
PL (1) | PL125596B1 (da) |
SE (1) | SE431092B (da) |
ZA (1) | ZA803827B (da) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4443450A (en) * | 1982-04-15 | 1984-04-17 | Research Corporation | Platelet aggregation inhibitory agents and intermediates therefor |
US4556664A (en) * | 1984-03-13 | 1985-12-03 | Gunnar A. K. Aberg | Method and composition for the treatment of cardiac arrhythmias |
US4695576A (en) * | 1984-07-09 | 1987-09-22 | Astra Lake Medel Aktiebolag | L-N-n-propylpipecolic acid-2,6-xylidide |
SE451840B (sv) * | 1986-01-03 | 1987-11-02 | Astra Laekemedel Ab | Optiskt rent monohydrat av s-(-)-1-propyl-2',6'-pipekoloxylididhydroklorid, sett att framstella denna och farmaceutiska beredningar for lokalbedovning |
US4859685A (en) * | 1986-08-13 | 1989-08-22 | Boc, Inc. | Anesthetic composition and method of using the same |
US5234957A (en) * | 1991-02-27 | 1993-08-10 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
US5446070A (en) * | 1991-02-27 | 1995-08-29 | Nover Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
US5332576A (en) * | 1991-02-27 | 1994-07-26 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
BR0002246A (pt) * | 2000-04-06 | 2003-04-15 | Cristalia Prod Quimicos Farm | Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis |
WO2002072582A1 (en) | 2001-03-12 | 2002-09-19 | Ortho-Mcneil Pharmaceutical, Inc. | Methods for the synthesis of densely functionalized pyrrolidine template libraries |
US8765167B2 (en) | 2001-10-12 | 2014-07-01 | Monosol Rx, Llc | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
US20190328679A1 (en) | 2001-10-12 | 2019-10-31 | Aquestive Therapeutics, Inc. | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
US7910641B2 (en) | 2001-10-12 | 2011-03-22 | Monosol Rx, Llc | PH modulated films for delivery of actives |
US7425292B2 (en) | 2001-10-12 | 2008-09-16 | Monosol Rx, Llc | Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
US20070281003A1 (en) | 2001-10-12 | 2007-12-06 | Fuisz Richard C | Polymer-Based Films and Drug Delivery Systems Made Therefrom |
US11207805B2 (en) | 2001-10-12 | 2021-12-28 | Aquestive Therapeutics, Inc. | Process for manufacturing a resulting pharmaceutical film |
US7666337B2 (en) | 2002-04-11 | 2010-02-23 | Monosol Rx, Llc | Polyethylene oxide-based films and drug delivery systems made therefrom |
US8900498B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for manufacturing a resulting multi-layer pharmaceutical film |
US20110033542A1 (en) | 2009-08-07 | 2011-02-10 | Monosol Rx, Llc | Sublingual and buccal film compositions |
US8900497B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for making a film having a substantially uniform distribution of components |
US8663687B2 (en) | 2001-10-12 | 2014-03-04 | Monosol Rx, Llc | Film compositions for delivery of actives |
US7357891B2 (en) * | 2001-10-12 | 2008-04-15 | Monosol Rx, Llc | Process for making an ingestible film |
US10285910B2 (en) | 2001-10-12 | 2019-05-14 | Aquestive Therapeutics, Inc. | Sublingual and buccal film compositions |
US8603514B2 (en) | 2002-04-11 | 2013-12-10 | Monosol Rx, Llc | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
US8017150B2 (en) | 2002-04-11 | 2011-09-13 | Monosol Rx, Llc | Polyethylene oxide-based films and drug delivery systems made therefrom |
US20070172515A1 (en) * | 2006-01-20 | 2007-07-26 | Monosolrx, Llc | Film bandage for mucosal administration of actives |
WO2008036299A2 (en) | 2006-09-20 | 2008-03-27 | Monosol Rx Llc | Edible water-soluble film containing a foam reducing flavoring agent |
US8475832B2 (en) | 2009-08-07 | 2013-07-02 | Rb Pharmaceuticals Limited | Sublingual and buccal film compositions |
ES2569339T3 (es) | 2010-06-10 | 2016-05-10 | Midatech Ltd. | Sistemas de administración de película de nanopartículas |
US9149959B2 (en) | 2010-10-22 | 2015-10-06 | Monosol Rx, Llc | Manufacturing of small film strips |
EP3380080B1 (en) | 2015-11-23 | 2021-09-22 | Nortic Holdings Inc. | Topical film-forming spray |
JP2019519487A (ja) | 2016-05-05 | 2019-07-11 | アクエスティブ セラピューティクス インコーポレイテッド | 送達増強エピネフリン組成物 |
US11273131B2 (en) | 2016-05-05 | 2022-03-15 | Aquestive Therapeutics, Inc. | Pharmaceutical compositions with enhanced permeation |
KR20210106503A (ko) | 2018-12-19 | 2021-08-30 | 노틱 홀딩스 잉크. | 비강내 리도카인의 치료 조성물 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE191321C1 (da) | 1964-01-01 | |||
SE191322C1 (da) | 1964-01-01 | |||
SE164063C1 (da) | 1958-07-22 | |||
US2792399A (en) * | 1954-05-29 | 1957-05-14 | Bofors Ab | Anilides of heterocyclic compounds |
US2799679A (en) * | 1955-04-28 | 1957-07-16 | Bofors Ab | Process of preparing amides of heterocyclic carboxylic acids |
GB889225A (da) * | 1959-07-01 | |||
NL6803337A (da) | 1967-03-20 | 1968-09-23 | ||
SE7607114L (sv) * | 1976-06-22 | 1977-12-23 | Bofors Ab | Sett att framstella hydrokloriden av n-metylpiperidin-2-karbonsyra-2,6-xyllidid |
GB1561023A (en) * | 1977-04-22 | 1980-02-13 | Beecham Group Ltd | 2-methoxy - 5 - chloro aniline derivatives |
US4146628A (en) * | 1977-08-04 | 1979-03-27 | Edna Oppenheimer | Antiarrhythmic quinuclidine carboxylic acid xylidide and method of producing the same and similar compounds |
DE2742582A1 (de) * | 1977-09-22 | 1979-04-05 | Hoechst Ag | Substituierte piperidinhydroxyamide, ihre herstellung und verwendung als lichtschutzmittel |
-
1979
- 1979-07-10 SE SE7906000A patent/SE431092B/sv not_active IP Right Cessation
- 1979-11-26 US US06/097,148 patent/US4302465A/en not_active Expired - Lifetime
-
1980
- 1980-06-25 IL IL60390A patent/IL60390A/xx unknown
- 1980-06-26 ZA ZA00803827A patent/ZA803827B/xx unknown
- 1980-06-27 DE DE8080850106T patent/DE3066827D1/de not_active Expired
- 1980-06-27 EP EP80850106A patent/EP0024382B1/en not_active Expired
- 1980-06-27 AT AT80850106T patent/ATE6507T1/de not_active IP Right Cessation
- 1980-07-02 AU AU60032/80A patent/AU538494B2/en not_active Ceased
- 1980-07-04 CA CA000355487A patent/CA1162924A/en not_active Expired
- 1980-07-04 DK DK290180A patent/DK290180A/da not_active Application Discontinuation
- 1980-07-07 FI FI802173A patent/FI802173A/fi not_active Application Discontinuation
- 1980-07-08 JP JP9232480A patent/JPS5681561A/ja active Granted
- 1980-07-08 PL PL1980225542A patent/PL125596B1/pl unknown
- 1980-07-09 CS CS804889A patent/CS227011B2/cs unknown
- 1980-07-09 HU HU80801712A patent/HU180156B/hu unknown
- 1980-07-09 GR GR62416A patent/GR69077B/el unknown
- 1980-07-09 NO NO802062A patent/NO802062L/no unknown
- 1980-07-09 ES ES493230A patent/ES8107185A1/es not_active Expired
- 1980-07-09 NZ NZ194284A patent/NZ194284A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ZA803827B (en) | 1981-06-24 |
JPS5681561A (en) | 1981-07-03 |
AU6003280A (en) | 1981-01-15 |
US4302465A (en) | 1981-11-24 |
SE431092B (sv) | 1984-01-16 |
US4302465B1 (da) | 1984-01-24 |
IL60390A (en) | 1984-10-31 |
NZ194284A (en) | 1983-06-14 |
FI802173A (fi) | 1981-01-11 |
HU180156B (en) | 1983-02-28 |
AU538494B2 (en) | 1984-08-16 |
GR69077B (da) | 1982-04-26 |
PL125596B1 (en) | 1983-05-31 |
EP0024382A1 (en) | 1981-03-04 |
NO802062L (no) | 1981-01-12 |
PL225542A1 (da) | 1981-12-23 |
ES493230A0 (es) | 1981-08-16 |
CA1162924A (en) | 1984-02-28 |
ES8107185A1 (es) | 1981-08-16 |
DE3066827D1 (en) | 1984-04-12 |
SE7906000L (sv) | 1981-01-20 |
JPS6135178B2 (da) | 1986-08-12 |
DK290180A (da) | 1981-01-11 |
ATE6507T1 (de) | 1984-03-15 |
EP0024382B1 (en) | 1984-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CS227011B2 (en) | Method of preparing substituted piperidines | |
DE69525355T2 (de) | 1-acyl-4-aliphatische aminopiperidin verbindungen | |
US3900481A (en) | Derivatives of pyrrolidine and piperidine | |
DK171748B1 (da) | Stabile opløsningsmiddeladdukter, fremgangsmåde til fremstilling deraf, lægemiddel indeholdende addukterne samt anvendelse af addukterne | |
BR112021005941A2 (pt) | pró-fármaco de nitroxolina e uso do mesmo | |
NZ194614A (en) | 4-(3-substitutedamino-2-hydroxypropoxy)indoles | |
US4097481A (en) | Tertiary amide derivatives of pyrrolidine and piperidine | |
PT96303B (pt) | Processo para a preparacao de novos derivados do acido piperidinocarboxilico com accao anestesica local e analgesica e de composicoes farmaceuticas que os contem | |
PT1185267E (pt) | Agentes anestesicos dermicos | |
CA2265053A1 (en) | Nitrone derivatives | |
CS214700B2 (en) | Method of making the 9-aminoalcylfluorenes | |
US6362203B1 (en) | 4-hydroxy-4-phenylpiperidine derivatives and pharmaceuticals containing the same | |
CS274287B2 (en) | Method of azoniaspironortropanol esters production | |
EP1325912A1 (en) | 2,2-diphenylbutanamide derivatives and medicines containing the same | |
KR0181945B1 (ko) | N,n'-비스(알콕시알킬)-피리딘-2,4-디카복실산 디아미드, 이의 제조방법 및 이를 함유하는 약제학적 조성물 | |
US4339587A (en) | 5-Benzyloxy or 5-hydroxy-2-(2,2,2-trifluoroethoxy)-N-(2-pyridylmethyl)benzamide | |
CS239948B2 (en) | Processing of substitute n-carboxamidealkylfenoxypropanolamine | |
SI9300217A (sl) | Farmacevtiki, ki vsebujejo ariloksialkilamino in ariltioalkilamino derivate | |
GB2235198A (en) | Novel aminopropanol derivatives | |
PT703915E (pt) | Xamoneline tartrato | |
US3723416A (en) | Substituted 2-arylalkyloxy benzamides | |
US3481980A (en) | Process and intermediates for n-(4-(2-alkylaminoalkoxy) - benzyl) - 3,4-dialkoxy benzamides | |
PT98184A (pt) | Processo de preparacao de derivados de 5-isotiazolamina e de composicoes farmaceuticas que os contem | |
US4161532A (en) | N-(1'-ethyl-2'-oxo-5'-pyrrolidinylmethyl) benzamide compounds and derivatives, method of preparation and pharmaceutical preparations | |
US2704284A (en) | Therapeutic compounds |